Recent research focusing on Semaglutide at a dosage of 20mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may enhance the drug's ability to control blood glucose, potentially offering improved outcomes for individuals with insulin resistance. Further study is underway to fully explore the long-